gefitinib has been researched along with Carcinoma, Mucoepidermoid in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dong, B; Guo, Y; He, Z; Li, S; Qin, J; Sun, Y; Tang, H; Wang, L; Wang, Q; Wu, Y; Yang, S; Yu, H; Zhang, Y | 1 |
| Deluca, KA; Jaskoll, T; Melnick, M | 1 |
| Chang, Y; Gao, Y; He, Z; Li, S; Liu, K; Ma, J; Ma, W; Ma, Z; Tang, H; Wang, Q; Wei, B; Zhang, Z | 1 |
| Dahse, R; Kosmehl, H | 1 |
| O'Neill, ID | 1 |
| Bai, CX; Garfield, D; Ge, HY; Song, YL; Wang, X; Wang, XY; Xu, N; Yang, P; Zhang, X | 1 |
| Bang, YJ; Chung, DH; Han, SW; Heo, DS; Im, SA; Jeon, YK; Kim, DW; Kim, HP; Kim, TY; Lee, SH; Oh, DY | 1 |
1 review(s) available for gefitinib and Carcinoma, Mucoepidermoid
| Article | Year |
|---|---|
Pathological complete response to gefitinib in a 10-year-old boy with EGFR-negative pulmonary mucoepidermoid carcinoma: a case report and literature review.
Topics: Carcinoma, Mucoepidermoid; Child; DNA-Binding Proteins; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Male; Mutation; Neoadjuvant Therapy; Neoplasm Staging; Oncogene Proteins, Fusion; Protein Kinase Inhibitors; Quinazolines; Tomography, X-Ray Computed; Transcription Factors; Treatment Outcome | 2017 |
6 other study(ies) available for gefitinib and Carcinoma, Mucoepidermoid
| Article | Year |
|---|---|
Gefitinib Represses JAK-STAT Signaling Activated by CRTC1-MAML2 Fusion in Mucoepidermoid Carcinoma Cells.
Topics: Biomarkers, Tumor; Carcinoma, Mucoepidermoid; Cell Line, Tumor; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Janus Kinases; Oncogene Proteins, Fusion; Signal Transduction; STAT1 Transcription Factor; Trans-Activators; Transcription Factors | 2019 |
CMV-induced pathology: pathway and gene-gene interaction analysis.
Topics: Animals; Carcinoma, Mucoepidermoid; Cytomegalovirus; Cytomegalovirus Infections; Epistasis, Genetic; Female; Gefitinib; Gene Expression Regulation; Gene Regulatory Networks; Humans; Mice; Mice, Inbred C57BL; Models, Theoretical; Organ Culture Techniques; Protein Kinase Inhibitors; Quinazolines; Salivary Gland Neoplasms; Salivary Glands; Signal Transduction; Tumor Microenvironment | 2014 |
Detection of drug-sensitizing EGFR exon 19 deletion mutations in salivary gland carcinoma.
Topics: Aged; Carcinoma, Adenoid Cystic; Carcinoma, Mucoepidermoid; DNA, Neoplasm; Drug Resistance; ErbB Receptors; Erlotinib Hydrochloride; Exons; Female; Gefitinib; Humans; Male; Middle Aged; Mutation; Parotid Neoplasms; Protein Kinase Inhibitors; Quinazolines | 2008 |
Gefitinib as targeted therapy for mucoepidermoid carcinoma of the lung: possible significance of CRTC1-MAML2 oncogene.
Topics: Carcinoma, Mucoepidermoid; DNA-Binding Proteins; ErbB Receptors; Gefitinib; Humans; Lung Neoplasms; Oncogene Proteins, Fusion; Protein Kinase Inhibitors; Quinazolines; Trans-Activators; Transcription Factors | 2009 |
FoxM1 mediated resistance to gefitinib in non-small-cell lung cancer cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Mucoepidermoid; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Flow Cytometry; Forkhead Box Protein M1; Forkhead Transcription Factors; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Quinazolines; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Time Factors | 2012 |
Mucoepidermoid carcinoma of lung: potential target of EGFR-directed treatment.
Topics: Adult; Antineoplastic Agents; Carcinoma, Mucoepidermoid; ErbB Receptors; Female; Gefitinib; Humans; Lung Neoplasms; Male; Middle Aged; Mutation; Protein Kinase Inhibitors; Quinazolines | 2008 |